Research
And Grants
Note: When clicking the "Submit Grant Application" button below you will be redirected to SnapGrant.com to complete the application process.
Submit Grant ApplicationThe Cure Starts Now follows an extensive grant approval process to ensure your dollars make the biggest impact to homerun cancer research. Take comfort in knowing that The Cure Starts Now only funds: research that follows our mission, research that is non-duplicative, and research that is financially sound.
The Cure Starts Now has funded $25,466,182 (USD) in pediatric brain cancer research in partnership with the DIPG / DMG Collaborative. This includes 170 grants at over 100 hospitals in 29 countries.

The Institute of Cancer Research - $100,000
$100,000.00
October 2018
Short-pulse Ultrasound Delivery of Panobinostat for the Treatment of Diffuse Intrinsic Gliomas in Children

The Institute of Cancer Research - $106,647
$106,647.00
October 2018
A Mouse Model of HIST1H3B/ACVR1 Mutant DIPG.

Johns Hopkins Children's Center - $50,000
$50,000.00
July 2018
Using Zebrafish to Accelerate DIPG Drug Development.

Funding of PBTCF 2018: PBTC-058 - $16,800
$16,800.00
January 2018
PBTC-058: Phase 2 Study of Intraventricular Omburtamab-based Radioimmunotherapy for Pediatric Patients with Recurrent Medulloblastoma and Ependymoma

The Campbell Family Institute for Cancer Research - $100,000
$100,000.00
October 2017
Defining the molecular mechanisms of DIPG development and progression to uncover novel therapeutic targets

Institute of Cancer Research - $102,432
$102,432.00
October 2017
Combinational strategies alongside ACVR1 inhibition in DIPG

The Regents of the University of California - $70,000
$70,000.00
October 2017
An Open Label Single Arm Phase I/II study of MTX110 delivered by convection-enhanced delivery (CED) in patients with diffuse intrinsic pontine glioma (DIPG) previously treated with external beam radiation therapy

The Hospital for Sick Children - $100,560
$100,560.00
October 2017
MRI Guided Focused Ultrasound: Towards Clinical Translation in Diffuse Intrinsic Pontine Glioma (DIPG)

Texas Children's Hospital and Ann & Robert H. Lurie Children's Hospital of Chicago - $200,000
$200,000.00
October 2017
Targeting DIPG through Combining a Super-activator (MCB-613) of Steroid Receptor Co-activators with Radiation.

Gustave Roussy - $101,868
$101,868.00
October 2017
Elucidating the underlying mechanisms of radio resistance at diagnosis and relapse in DIPG

Ospedale Pediatrico Bambino Gesu - $98,987
$98,987.00
October 2017
Investigating the role of DIPG-derived exosomes in tumor growth and invasion

Memorial Sloan Kettering Cancer Center - $100,000
$100,000.00
October 2017
Targeting EZH2 as a therapeutic strategy in DIPG

Dana-Farber Cancer Institute - $82,863
$82,863.00
October 2017
Defining the Cellular Architecture of Diffuse Intrinsic Pontine Glioma through Large-Scale Single-cell RNA-sequencing analyses

The Hospital of Sick Children - $162,828
$162,828.00
October 2017
Targeting DIPG through pharmacological activation of mitochondrial biogenesis: an in vitro and in vivo preclinical study

Stanford University - $200,000
$200,000.00
October 2017
Targeting neuronal activity regulated DIPG infiltration